Physician

Richard Randolph Schulze, MD

According to 2025 Medicare claims, Richard Schulze, MD (NPI: 1205815743) practices ophthalmology in the Savannah, GA market, with the plurality of this provider's patient population coming from Chatham, GA. This provider's primary affiliated billing organization is SCHULZE EYE CENTER, P.C. (NPI: 1235118621; TIN: 58-1095110) and primary practice location at 31405-4608.

Schulze's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,462 traditional Medicare patients, billed 4,865 HCPCS/CPT codes, and received $397,779 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 2,860 prescription claims across 589 beneficiaries totaling $177,459 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 6 records totaling $225. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$234K$467K2015 Medicare payment: $467,127 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $457,839 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $439,895 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $442,439 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $427,119 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $302,250 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $403,364 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $370,377 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $383,581 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $397,779 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,3464,273$467,127
20161,3664,502$457,839
20171,3994,541$439,895
20181,3834,572$442,439
20191,3904,701$427,119
20201,1453,557$302,250
20211,4214,607$403,364
20221,4964,617$370,377
20231,4424,611$383,581
20241,4624,865$397,779

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$150K$300K2015 Drug cost: $162,526 (USD; Tot_Drug_Cst)2016 Drug cost: $189,978 (USD; Tot_Drug_Cst)2017 Drug cost: $219,698 (USD; Tot_Drug_Cst)2018 Drug cost: $188,280 (USD; Tot_Drug_Cst)2019 Drug cost: $193,529 (USD; Tot_Drug_Cst)2020 Drug cost: $186,919 (USD; Tot_Drug_Cst)2021 Drug cost: $300,141 (USD; Tot_Drug_Cst)2022 Drug cost: $236,901 (USD; Tot_Drug_Cst)2023 Drug cost: $209,864 (USD; Tot_Drug_Cst)2024 Drug cost: $177,459 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20155432,836$162,526
20166373,333$189,978
20176463,301$219,698
20184802,774$188,280
20195102,678$193,529
20204692,345$186,919
20215102,382$300,141
20225182,548$236,901
20235562,619$209,864
20245892,860$177,459

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system789799$73
92012Established patient problem focused exam of visual system483828$55
92136Measurement of corneal curvature and depth of eye339342$27
92250Photography of the retina503508$23
92285Photography of content of eyes507552$14

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine201,110$22,902
LumiganBimatoprost421,824$18,590
VyzultaLatanoprostene Bunod611,828$16,300
XiidraLifitegrast13510$11,513
Prednisolone AcetatePrednisolone Acetate24610,094$9,563

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$225Carl Zeiss Meditec USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Richard Randolph Schulze, MD?

Tedicare shows public-source Medicare data for Richard Randolph Schulze, MD (NPI 1205815743), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard Randolph Schulze, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Richard Randolph Schulze, MD?

Richard Randolph Schulze, MD is linked to SCHULZE EYE CENTER, P.C. (billing NPI 1235118621) in the available physician profile data.

Does Richard Randolph Schulze, MD have Open Payments data?

Richard Randolph Schulze, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.